PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportstrigeminal neuralgia
MeSH D014277 - trigeminal neuralgia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020433:Trigeminal nerve diseases
0 Companies
0 Drugs
Success rate
D014277: 
Trigeminal neuralgia
58 Companies
4 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBaclofen Baclofen  1988-07-21   
Carbamazepine Carbamazepine  2012-09-20   
Carbamazepine Epitol  1986-09-17   
Novast LaboratoriesCarbamazepine Carbamazepine  2022-12-02   
Taro PharmaceuticalCarbamazepine Carbamazepine  1996-10-03   
Carbamazepine Teril  2003-09-26   
MylanBaclofen Baclofen  2005-07-29   
NovartisBaclofen Lioresal  1982-01-01   
Carbamazepine Tegretol  1982-01-01   
UCBBaclofen Kemstro  2003-10-30   
TakedaCarbamazepine Carbatrol  1997-09-30   
Aurobindo PharmaBaclofen Baclofen  2021-07-13   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
71%
5/7
Phase 2
50%
9/18
Phase 3
42%
5/12
Approved: 4Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Baclofen
Novartis
Baclofen,
Carbamazepine
UCB
Baclofen
Dr Reddys Laboratories
Tizanidine
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use